Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Medacta Group SA, CH0468525222

Medacta Group SA, CH0468525222

14.07.2021 - 19:03:08

EQS-News: Medacta Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform

About Medacta Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta's innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries.

End of Media Release

Language: English Company: Medacta Group SA Strada Regina 6874 Castel San Pietro

Switzerland Phone: +41 91 696 6060 E-mail: info@medacta.ch Internet: www.medacta.com ISIN: CH0468525222 Listed: SIX Swiss Exchange EQS News ID: 1218415 ? End of News EQS Group News Service


@ dgap.de